Reslizumab en el asma eosinofílica no controlada
Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M. Reslizumab f..
Leer más
Patient-reported outcome measures in severe asthma: an expert consensusBenralizumab vs Mepolizumab para la Granulomatosis Eosinofílica con Poliangeítis (GEPA)Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study.Respuesta clínica y remisión en pacientes con asma grave tratados con terapias biológicasAssociation Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma